See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
Patient organizations are critical players in the health system, focused on improving the lives of patients and their loved ones as they cope with health conditions. As life sciences companies increasingly aim to be patient-centric, they have partnered with patient organizations to better understand what patients experience along their care journey, advance research and drug development, and improve clinical trial designs to better meet patient needs. However, despite shared interests, collaborative relationships between the two stakeholders have had their challenges.
Understanding the role and perspectives of patient organizations in these partnerships can help life sciences companies forge better and more productive collaborations. As patient organizations have expanded the scope of their work — acting as expert scientific and data partners to industry — understanding the breadth of what they offer can open new opportunities for collaboration.
This report examines the different types of patient organizations, the dynamics affecting them and the activities they conduct. It explores where collaborations with life sciences companies are occurring, where they have been successful, and where patient organizations have indicated there is room for improvement. It also examines growing areas of focus for patient organizations where they may seek or provide support and collaboration.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
Accelerate the development of new therapies.
Take advantage of the latest tools, techniques, and deep healthcare expertise to create scalable resources, precision insights, and actionable ideas.
Effectively engage with patients to help improve adherence, drive better disease understanding, and deliver treatment value.